Uncertainties in internal dose calculations for radiopharmaceuticals

Journal of Nuclear Medicine

Volumn 49, Issue 5, 2008, Pages 853-860

  Stabin, Michael G ^a  

^a VANDERBILT UNIVERSITY   (United States)

Author keywords

Internal dose assessment; Radiation safety; Radiobiology dosimetry; Radiopharmaceuticals; Uncertainty

Indexed keywords

ARTICLE; CELL LEVEL; DIAGNOSTIC ACCURACY; DOSE CALCULATION; DOSIMETRY; HUMAN; IMAGE QUALITY; KINETICS; MATHEMATICAL COMPUTING; MATHEMATICAL PARAMETERS; NONHUMAN; ORGAN SIZE; PRIORITY JOURNAL; RADIATION ABSORPTION; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RADIODIAGNOSIS; RISK ASSESSMENT; TISSUE LEVEL;

FEMALE; HUMANS; MALE; MODELS, BIOLOGICAL; RADIATION DOSAGE; RADIOMETRY; RADIOPHARMACEUTICALS; RADIOTHERAPY DOSAGE; SENSITIVITY AND SPECIFICITY; UNCERTAINTY;

EID: 44149101477     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.107.048132     Document Type: Article

References (41)

1. Cristy M, Eckerman K. Specific Absorbed Fractions of Energy at Various Ages from Internal Photon Sources. Oak Ridge, TN: Oak Ridge National Laboratory; 1987. ORNL/TM-8381 V1-V7.
2. Segars JP. Development and Application of the New Dynamic NURBS-Based Cardiac-Torso (NCAT) Phantom [dissertation]. Chapel Hill, NC: University of North Carolina; 2001.
3. International Commission on Radiological Protection. Basic Anatomical and Physiological Data for Use in Radiological Protection: Reference Values. New York, NY: Pergamon Press; 2003. ICRP publication 89.
4. Stabin MG, Sparks RB, Crowe E. OLINDA/EXM: The second-generation personal computer software for internal dose assessment in nuclear medicine. J Nucl Med. 2005;46:1023-1027.
5. Roger DF. An Introduction to NURBS with Historical Perspective. San Francisco, CA: Morgan Kaufmann Publishers; 2001.
6. de la Grandmaison GL, Clairand I, Durigona M. Organ weight in 684 adult autopsies: new tables for a Caucasoid population. Forensic Sci Int. 2001;119:149-154.
7. Gesner JA, Stabin MG, Rogers JA. Analysis of uncertainty in nuclear medicine dose estimation [abstract]. J Nucl Med. 2007;48(suppl): 297P.
8. Siegel JA, Thomas SR, Stubbs JB, et al. MIRD pamphlet no. 16: techniques for quantitative radiopharmaceutical biodistribution data acquisition and analysis for use in human radiation dose estimates. J Nucl Med. 1999;40(suppl):37S-61S.
9. Hammond ND, Moldofsky PJ, Beardsley MR, Mulhern CB Jr. External imaging techniques for quantification of distribution of I-131 F(ab′)2 fragments of monoclonal antibody in humans. Med Phys. 1984;11:778-783.
10. Eary JF, Appelbaum FL, Durack L, Brown P. Preliminary validation of the opposing view method for quantitative gamma camera imaging. Med Phys. 1989;16:382-387.
11. Green AJ, Dewhurst SE, Begent RHJ, Bagshawe KS, Riggs SJ. Accurate quantification of 131 I distribution by gamma camera imaging. Eur J Nucl Med. 1990;16:361-365.
12. 131I. J Nucl Med. 2002;43:972-982.
13. Norrgren K, Svegborn SL, Areberg J, Mattsson S. Accuracy of the quantification of organ activity from planar gamma camera images. Cancer Biother Radiopharm. 2003;18:125-131.
14. Jönsson L, Ljungberg M, Strand SE. Evaluation of accuracy in activity calculations for the conjugate view method from Monte Carlo simulated scintillation camera images using experimental data in an anthropomorphic phantom. J Nucl Med. 2005;46:1679-1686.
15. Jaszczak RJ, Coleman RE, Whitehead FR. Physical factors affecting quantitative measurements using camera-based single photon emission computed tomography (SPECT). IEEE Trans Nucl Sci. 1981;28:69-80.
16. Gilland DR, Jaszczak RJ, Turkington GT, Greer KL, Coleman RE. Volume and activity quantitation with iodine-123 SPECT. J Nucl Med. 1994;35:1707-1713.
17. Koral KF, Yendiki A, Lin Q, Dewaraja YK, Fessler JA. Determining total I-131 activity within a voi using SPECT, a UHE collimator, OSEM, and constant conversion factor. IEEE Trans Nucl Sci. 2004;51:611-618.
18. 166Ho-DOTMP radiation-absorbed dose estimation for skeletal targeted radiotherapy. J Nucl Med. 2006;47:534-542.
19. 198Au-colloidal gold. J Nucl Med. 1975;16:173-174.
20. Aydogan B, Sparks RB, Stubbs JB, Miller LF. Uncertainty analysis for absorbed dose from a brain receptor agent. In: Stelson A, Stabin M, Sparks R, eds. Sixth International Radiopharmaceutical Dosimetry Symposium. Oak Ridge, TN: Oak Ridge Associated Universities; 1999:732-740.
21. Sparks RB, Aydogan B. Comparison of the effectiveness of some common animal data scaling techniques in estimating human radiation dose. In: Stelson A, Stabin M, Sparks R, eds. Sixth International Radiopharmaceutical Dosimetry Symposium. Oak Ridge, TN: Oak Ridge Associated Universities; 1999:705-716.
22. International Commission on Radiological Protection. Recommendations of the International Commission on Radiological Protection. New York, NY: Pergamon Press; 1977. ICRP Publication 26.
23. Poston JW. Application of the effective dose equivalent to nuclear medicine patients. J Nucl Med. 1993;34:714-716.
24. International Commission on Radiological Protection. Protection of the Patient in Nuclear Medicine. New York, NY: Pergamon Press; 1987. ICRP publication 52.
25. International Commission on Radiological Protection. Radiation Dose to Patients from Radiopharmaceuticals. New York, NY: Pergamon Press; 1988. ICRP publication 53.
26. International Commission on Radiological Protection. Radiation Dose from Radiopharmaceuticals. Addendum to ICRP 53. Philadelphia, PA: Elsevier Health; 2007. ICRP publication 80, 1998.
27. International Commission on Radiological Protection. Limits for Intakes of Radionuclides by Workers. New York, NY: Pergamon Press; 1979. ICRP publication 30.
28. International Commission on Radiological Protection. 1990 Recommendations of the International Commission on Radiological Protection. New York, NY: Pergamon Press; 1991. ICRP publication 60.
29. Committee on Health Effects of Exposure to Low Levels of Ionizing Radiations (BEIR VII), National Research Council. Health Risks from Exposure to Low Levels of Ionizing Radiation BEIR VII Phase 2. Washington, DC: National Academies Press; 2006.
30. Rao DV, Govelitz DF, Sastry KSR. Radiotoxicity of thallium-201 in mouse testes: inadequacy of conventional dosimetry. J Nucl Med. 1983;24:145-153.
31. Rao DV, Sastry KS, Grimmond H, et al. Cytotoxicity of some indium radiopharmaceuticals in mouse testes. J Nucl Med. 1988;29:1375-1384.
32. Gardin I, Colas Linhart N, Petiet A, Bok B. Dosimetry at the cellular level of Kupffer cells after technetium-99m-sulphur colloid injection. J Nucl Med. 1992;33:380-384.
33. Robinson MS, Colas-Linhart NC, Guiraud-Vitaux FM, Petiet AM, Bok BD. Heterogeneous distribution of technetium-99m-labeled microspheres in rat lungs: microautoradiographic evidence and dosimetric consequences. J Nucl Med. 1997;38:650-654.
34. Roeske JC, Stinchcomb TG. Dosimetric framework for therapeutic alpha-particle emitters. J Nucl Med. 1997;38:1923-1929.
35. Rossi HH, Biavati MH, Gross W. Local energy density in irradiated tissues. I. Radiobiological significance. Radiat Res. 1961;15:431-439.
36. 213Bi-HuM195 (Anti-CD33) in patients with leukemia. J Nucl Med. 1999;40:1935-1946.
37. Flux GD, Webb S, Ott RJ, Chittenden SJ, Thomas R. Three-dimensional dosimetry for intralesional radionuclide therapy using mathematical modeling and multimodality imaging. J Nucl Med. 1997;38:1059-1066.
38. Wessels BW, Griffith MH. Miniature thermoluminescent dosimeter absorbed dose measurements in tumor phantom models. J Nucl Med. 1986;27:1308-1314.
39. Jarnet D, Denizot B, Hindre F, et al. New thermoluminescent dosimeters (TLD): optimization and characterization of TLD threads sterilizable by autoclave. Phys Med Biol. 2004;49:1803-1815.
40. Roedler HD. Accuracy of internal dose calculations with special consideration of radiopharmaceutical biokinetics. In: Third International Radiopharmaceutical Dosimetry Symposium. Rockville, MD: Department of Health and Human Welfare, Bureau of Radiological Health; 1981. HHS publication FDA 81-8166.
41. Zanzonico PB. Internal radionuclide radiation dosimetry: a review of basic concepts and recent developments. J Nucl Med. 2000;41:297-308.